Cancer Biomarkers Conference IV

Final - CBCIV w  Bootcamp Banner

Program Overview

Program Director - Philip T. Cagle, MD, University of Mississippi Medical Center 

The field of biomarker testing for targets of tyrosine kinase inhibitor therapy and immune therapy is constantly advancing with introduction of new tests and new therapies. The Cancer Biomarker Conference (CBC) series provides real-world practical updates for general community pathologists, molecular pathologists, oncologists and related specialties and professions for this ever-changing field. The conference includes state-of-the-art lectures and panel discussions on specific biomarker testing in solid and hematologic malignancies for TKIs and immune therapies, liquid biopsy, next generation sequencing, preanalytic management, billing, regulations and malpractice for everyday practice as well as the needs and expectations of the oncologist. The CBC is now sponsored by the University of Mississippi Medical Center and the next two-day CME conference plus one day Boot Camp will take place at the Saddle Brook New Jersey Marriott in collaboration with local sponsor Princeton Medical Center. 

Sponsored By:

Sponsored by the The University of Mississippi School of Medicine , Department of Pathology, Princeton Medical Center and the University of Mississippi Medical Center, Division of Continuing Health Professional Education.

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!